Barely Significant
← all excerpts

Effects of a Safety Letter on Metoclopramide Use in Korea: An Interrupted Time-Series Analysis.

Risk Manag Healthc Policy · 2020 · PMC7457562 · PMID 32904722

Europe PMCDOI
1
hedged sentence
0.0100
closest p · 0.2× alpha
0.0100
boldest claim

The sentences

a decreasing trendp-value <0.01actually significant
The average dose per prescription per month (18.27–19.21 mg before the publication of the safety letter and 15.39–16.93 mg after the publication of safety letter) followed a decreasing trend before the safety letter (TIME1: −0.02, p-value <0.01).

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.